US sharps group seeks FDA action on safety
This article was originally published in Clinica
A new clinician advisory on healthcare worker safety is being requested by NAPPSI, the US sharps industry lobby group, founded by Carlsbad, California-based Venetec and to date comprising some 30 member companies. Estimates put the annual US sharps injury tally at 600,000-800,000, with some 2,500 cases involving life-threatening cases of HIV and hepatitis. In all, some 5.6m workers suffer occupational exposure bloodborne pathogens.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.